FDA grants orphan drug status to orziloben for intestinal failure-associated liver disease (90)Orziloben secures FDA orphan ...

The Glennon Intestinal Rehabilitation and Feeding (GIRAF) program was established in 2015 as the first multidisciplinary program of its kind in the region dedicated to the specific needs of pediatric ...

Pediatric intestinal failure occurs when patients lack the amount of intestine necessary for growth and development. As advances in treatment have led to better survival rates for children with short ...

Intestinal failure is defined as having an intestinal condition which renders a child unable to maintain adequate hydration and meet calorie absorption needs sufficient for growth. This results in ...

When parts of the small intestine are diseased or die, the treatment can involve surgically removing the affected tissue. Although lifesaving, the procedure—referred to as a radical small bowel ...

Researchers have developed a human intestinal cell model that closely mimics the structure and function of the human gut, enabling more precise prediction of drug-induced gastrointestinal toxicity ...

An infectious intestinal disease episode can be noted in both primary care and hospital admissions, with children and older adults having higher odds of admissions during a primary care episode.

Chronic intestinal pseudo-obstruction (CIPO) affects the movement of food, fluid, air, and waste through the intestines. It can be genetic or develop due to another health condition. CIPO is a rare ...

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, will present new findings at the American College of Gastroenterology (ACG) 2024 Annual ...